This is the final part of a three-part series examining the latest advancements in cell and gene therapy manufacturing.

Patent expirations and the rise of weight loss medications led to some surprises in the top 20 drugs by global sales. With more than 30 indications across various cancer types and stages, Merck’s Keytruda was top of the list last year. With $25 billion in global sales, the drug accounted for about 40% of Merck’s total

According to new research from ADP, “a strong work ethic” is the top skill companies are looking for in a new hire. Individuals who possess it are characteristically punctual, organized, efficient with their time, and most importantly, willing to go the extra mile to get the job done well.

As patients increasingly steer their own health journeys, pharma marketers have an opportunity to make an impact through health education that drives informed and proactive decision-making. They can do this by answering critical questions, anticipating needs and guiding the patient as they move forward, and open gateways to comprehensive support.

Artificial intelligence (AI) is a hot topic in business, amongst companies and their consumers alike. While the implementation of the technology has been met with uncertainty at times, it seems to have significantly boosted job satisfaction levels for customer service personnel – and in turn, improved the overall customer experience for consumers.

If you are in the process of updating your resume, consider replacing these words with stronger words.

Managed - use - Directed
Responsible for - use - Oversaw
Did - use - Accomplished
Helped - use - Crafted

According to Babbel’s survey of 2,000 US office workers, 88% of people have regretted a work email right after hitting send. According to Esteban Touma, a Cultural and Linguistics expert at Babbel, two big mistakes that can lead to regret are having typos and unclear messaging in the email.

The only two companies to have double-digit sales increases by revenue in 2023 were Novo Nordisk’s Ozempic and Eli Lily’s Mounjaro, mostly due to the popularity of injected weight loss drugs. Their revenue increase was 31% and 20% respectively.

Interesting data from a recent ContactBabel survey of 1,000 customers regarding Audio Improvement & Noise Reduction for effective call center communication.

Congratulations to my stepdaughter Sara Nugent on her first AJMC publication!

Here’s an up-to-date guide from Quantexa that delves into how AI is transforming decision-making for business leaders, providing essential knowledge and practical strategies.

An interesting look at PitchBook's Data Analytics report outlining the trends and critical opportunities that will define the industry in years to come. 

Fierce Pharma’s initial field of 32 is down to the Sweet 16.

Eli Lilly’s diabetes med Mounjaro strolled to victory over Bristol Myers Squibb’s heart drug Camzyos by 72% to 28%.

Asking for a pay raise is no easy feat, and according to a study done by Indeed, it is particularly for women. When looking around the world more than half of women have never asked for a raise and of the 43% who asked, three in four received a pay increase.

Having peaked in 2021 and plummeted as the pandemic ended, deal value revived in 2023, with pharma companies pursuing growth and medtech companies chasing profitability. These trends promise to continue in 2024.

Take a look at this interesting report on Q1 2024 US Market Insights by PitchBook.

AbbVie’s CEO, Richard Gonzalez, has announced he will step down as CEO on July 1st. At that time, he will become Executive Chairman of the board, and AbbVie’s current President and COO, Robert Michael will take over his role. Gonzalez has served as AbbVie’s CEO for 11 years.

According to recent research by Ringover, a cloud-based telecom provider, which surveyed over 1,200 people who have interviewed job candidates, the quickest way to make a bad first impression in a job interview is to show up late.

The biopharma industry mergers and acquisitions in 2023 did not outdo the highs of 2019 but they did surpass 2022, 2021, and 2020 with $115.8 million in total. Topping the 2023 list is Pfizer’s $43 billion merger with Seagen.

Fierce Pharma has put together a list of the most anticipated drug launches based on Evaluate Vantage’s 2024 preview. Typically, major pharmaceutical and biotechnology companies are featured however, this year things could be a little different as the top pick is from a company that many may not know, Karuna Therapeutics.